Adenoviral gene transfer of angiostatic ATF-BPTI inhibits tumour growth
BACKGROUND: The outgrowth of new vessels – angiogenesis – in the tumour mass is considered to be a limiting factor of tumour growth. To inhibit the matrix lysis that is part of the tumour angiogenesis, we employed the chimeric protein mhATF-BPTI, composed of the receptor binding part of the urokinas...
Αποθηκεύτηκε σε:
| Εκδόθηκε σε: | BMC Cancer |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BMC
2002
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC122087/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12147175/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-2407-2-17 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|